Company intelligence / Profile preview
Integra Therapeutics
Barcelona, Catalonia, Spainintegra-tx.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Integra Therapeutics is developing next-generation gene-writing tools to improve the safety and efficacy of advanced therapies. Their FiCAT platform combines CRISPR-Cas precision with the efficiency of an engineered piggybac transposase for gene insertion.
- Therapeutic areas
- Rare DiseasesImmunologyOncology
- Modalities
- Gene therapiescell therapies
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Licensing deal with Caszymecollaborations with Hospital Clínic Barcelona and part of the Catalan advanced therapies network
Beyond the preview
Go deeper on Integra Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Integra Therapeutics.